1-20 of 42
Hong Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Circadian Clock Component RORA Increases Immunosurveillance in Melanoma by Inhibiting PD-L1 Expression

Dandan Liu, Benliang Wei, Long Liang, Yue Sheng, Shengjie Sun, Xing Sun, Maohua Li, Haobo Li, Chaoying Yang, Yuanliang Peng, Yifang Xie, Chengcai Wen, Lu Chen, Xionghao Liu, Xiang Chen, Hong Liu, Jing Liu
Journal: Cancer Research
Cancer Res (2024) 84 (14): 2265–2281.
https://doi.org/10.1158/0008-5472.CAN-23-3942
Published: 15 July 2024
View article titled, The Circadian Clock Component RORA Increases Immunosurveillance in Melanoma by Inhibiting PD-L1 Expression
Open the PDF for The Circadian Clock Component RORA Increases Immunosurveillance in Melanoma by Inhibiting PD-L1 Expression in another window
Includes: Supplementary data
Journal Articles

Abstract 5802: An orally available small molecule JMBI-001 elicits MYC-synthetic lethality and anti-tumor immunity by disabling MKLP2-mediated cellular processes

Ting Zhang, Qiong Shi, Julia Kalashova, Xumei Liu, Xiaohu Zhou, Chenglu Yang, Yan Long, Hongmei Li, Jinhua Li, Gang Lv, Duo Yu, Xuejiao Jiang, Shenqiu Zhang, Jing Zhang, Hong Liu, Dun Yang
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5802.
https://doi.org/10.1158/1538-7445.AM2024-5802
Published: 22 March 2024
View article titled, Abstract 5802: An orally available small molecule JMBI-001 elicits MYC-synthetic lethality and anti-tumor immunity by disabling MKLP2-mediated cellular processes
Journal Articles

Abstract 3270: The XernaTM TME Panel potentially predicts response to a combination of the TLR9 agonist vidutolimod and PD-1 inhibitor pembrolizumab in metastatic melanomas with prior anti-PD-1 treatment

Mark T. Uhlik, Daniel Pointing, Luka Ausec, Miha Stajdohar, Robert Cvitkovic, Matjaz Zganec, Seema Iyer, Hong Liu, Art Krieg, Laura Benjamin
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3270.
https://doi.org/10.1158/1538-7445.AM2023-3270
Published: 04 April 2023
View article titled, Abstract 3270: The Xerna<sup>TM</sup> TME Panel potentially predicts response to a combination of the TLR9 agonist vidutolimod and PD-1 inhibitor pembrolizumab in metastatic melanomas with prior anti-PD-1 treatment
Journal Articles

Abstract P1-12-11: Real-world incidence and management of diarrhea secondary to pyrotinib in patients with HER-2 positive breast cancer

Hong Liu, Li Ma, Xu Wang, Xinzhong Chang, Qi Yu, Qingfeng Huang, Chunfang Hao, Jun Liu, Jing Zhao, Shufen Li, Zhongsheng Tong, Yehui Shi, Ning Lu, Weipeng Zhao, Tong Wang, Xuchen Cao, Chen Wang, Juntian Liu, Ying Zhao, Lina Zhang, Baoliang Guo, Xin Wang, Xu Di, Chunhui Gao, Zongzhan Liu, Shuo Sun, Linwei Li
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P1-12-11.
https://doi.org/10.1158/1538-7445.SABCS22-P1-12-11
Published: 01 March 2023
View article titled, Abstract P1-12-11: Real-world incidence and management of diarrhea secondary to pyrotinib in patients with HER-2 positive breast cancer
Journal Articles

Characterization of Immune-Related Alternative Polyadenylation Events in Cancer Immunotherapy

Gaoyang Wang, Zuozhong Xie, Juan Su, Meishan Chen, Yanhua Du, Qian Gao, Guanxiong Zhang, Hailun Zhang, Xiang Chen, Hong Liu, Leng Han, Youqiong Ye
Journal: Cancer Research
Cancer Res (2022) 82 (19): 3474–3485.
https://doi.org/10.1158/0008-5472.CAN-22-1417
Published: 04 October 2022
View article titled, Characterization of Immune-Related Alternative Polyadenylation Events in Cancer Immunotherapy
Open the PDF for Characterization of Immune-Related Alternative Polyadenylation Events in Cancer Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Abstract LB107: Novel transcriptional signatures associated with antitumor activity in vidutolimod (vidu)-treated patients (pts) with anti-PD-1-refractory melanoma and non-small cell lung cancer (NSCLC)

Hong Liu, Luping Zhao, Ping Zheng, Riyue Bao, Jason J. Luke, Marcelo V. Negrao, Shakoora A. Sabree, George J. Weiner, Sujatha Kumar, Dmitri Bobilev, James E. Wooldridge, Arthur M. Krieg
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): LB107.
https://doi.org/10.1158/1538-7445.AM2022-LB107
Published: 15 June 2022
View article titled, Abstract LB107: Novel transcriptional signatures associated with antitumor activity in vidutolimod (vidu)-treated patients (pts) with anti-PD-1-refractory melanoma and non-small cell lung cancer (NSCLC)
Journal Articles

Abstract P2-03-03: The comparison of genomic alteration characteristics of young women with breast cancer between Chinese and Western population

Hong Liu, Jinpu Yu, Zanmei Xu, Fei Wang, Yang Li, Siyue Zhang, Bin Wang, Beibei Yang, Xuesong Li
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P2-03-03.
https://doi.org/10.1158/1538-7445.SABCS21-P2-03-03
Published: 15 February 2022
View article titled, Abstract P2-03-03: The comparison of genomic alteration characteristics of young women with breast cancer between Chinese and Western population
Journal Articles

Abstract 2173: Genomic mutation characteristics and clinical implications of breast cancer in different age groups

Hong Liu, Jinpu Yu, Zanmei Xu, Fei Wang, Yang Li, Siyue Zhang, Bin Wang, Beibei Yang, Weifeng Wang
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2173.
https://doi.org/10.1158/1538-7445.AM2021-2173
Published: 01 July 2021
View article titled, Abstract 2173: Genomic mutation characteristics and clinical implications of breast cancer in different age groups
Journal Articles

LncRNA SNHG10 Facilitates Hepatocarcinogenesis and Metastasis by Modulating Its Homolog SCARNA13 via a Positive Feedback Loop

Tian Lan, Kefei Yuan, Xiaokai Yan, Lin Xu, Haotian Liao, Xiangyong Hao, Jinju Wang, Hong Liu, Xiangzheng Chen, Kunlin Xie, Jiaxin Li, Mingheng Liao, Jiwei Huang, Yong Zeng, Hong Wu
Journal: Cancer Research
Series: Author Choice
Cancer Res (2019) 79 (13): 3220–3234.
https://doi.org/10.1158/0008-5472.CAN-18-4044
Published: 01 July 2019
View article titled, LncRNA SNHG10 Facilitates Hepatocarcinogenesis and Metastasis by Modulating Its Homolog SCARNA13 via a Positive Feedback Loop
Open the PDF for LncRNA SNHG10 Facilitates Hepatocarcinogenesis and Metastasis by Modulating Its Homolog SCARNA13 via a Positive Feedback Loop in another window
Includes: Supplementary data
Journal Articles

Abstract 1537: Anti-CD19 ARTEMIS™ T cells prevent excessive inflammatory cytokine release, including IL-6, in a co-culture model of CRS

Hong Liu, Lucas H. Horan, Stephan A. Grupp, David M. Barrett, Cheng Liu
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 1537.
https://doi.org/10.1158/1538-7445.AM2018-1537
Published: 01 July 2018
View article titled, Abstract 1537: Anti-CD19 ARTEMIS™ T cells prevent excessive inflammatory cytokine release, including IL-6, in a co-culture model of CRS
Journal Articles

Loss of MED12 Induces Tumor Dormancy in Human Epithelial Ovarian Cancer via Downregulation of EGFR

Xiao-Lin Luo, Cheng-Cheng Deng, Xiao-Dong Su, Fang Wang, Zhen Chen, Xing-Ping Wu, Shao-Bo Liang, Ji-Hong Liu, Li-Wu Fu
Journal: Cancer Research
Cancer Res (2018) 78 (13): 3532–3543.
https://doi.org/10.1158/0008-5472.CAN-18-0134
Published: 01 July 2018
View article titled, Loss of MED12 Induces Tumor Dormancy in Human Epithelial Ovarian Cancer via Downregulation of EGFR
Open the PDF for Loss of MED12 Induces Tumor Dormancy in Human Epithelial Ovarian Cancer via Downregulation of EGFR in another window
Includes: Supplementary data
Journal Articles

Abstract 5503: Loss of MED12 induces tumor dormancy in human ovarian cancer

Xiao-Lin Luo, Cheng-Cheng Deng, Ji-Hong Liu, Li-Wu Fu
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 5503.
https://doi.org/10.1158/1538-7445.AM2018-5503
Published: 01 July 2018
View article titled, Abstract 5503: Loss of MED12 induces tumor dormancy in human ovarian cancer
Journal Articles

Abstract 2299: ET1402L1-CART, a T cell therapy targeting the intracellular tumor antigen AFP, demonstrates potent antitumor activity in hepatocellular carcinoma models

Hong Liu, Yiyang Xu, Jingyi Xiang, Li Long, Shon Green, Zhiyuan Yang, Jingwei Lu, Neal Cheng, Lucas H. Horan, Bin Liu, Su Yan, Pei Wang, Juan Diaz, Lian-xing Liu, Vivien Chan, Cheng Liu
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2299.
https://doi.org/10.1158/1538-7445.AM2016-2299
Published: 15 July 2016
View article titled, Abstract 2299: ET1402L1-CART, a T cell therapy targeting the intracellular tumor antigen AFP, demonstrates potent antitumor activity in hepatocellular carcinoma models
Journal Articles

Abstract 1980: Dihydroartemisinin inhibits ovarian cancer growth and metastasis via targeting PDGFRα

Xiaoguang Li, Yanling Liu, Qingxi Yue, Jianbing Zhang, Nuoxi Gong, Peizhan Chen, Hong Liu, Meiyu Geng, Fulin Qiang, Ruiwen Zhang, Hui Wang
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1980.
https://doi.org/10.1158/1538-7445.AM2012-1980
Published: 15 April 2012
View article titled, Abstract 1980: Dihydroartemisinin inhibits ovarian cancer growth and metastasis via targeting PDGFRα
Journal Articles

Abstract #3852: CCN1/ER/FOXO3a: A new connection in the hormonal response in breast cancer.

Ingrid Espinoza, Hong Liu, Robert C. Busby, Ruth Lupu
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 3852.
Published: 01 May 2009
View article titled, Abstract #3852: CCN1/ER/FOXO3a: A new connection in the hormonal response in breast cancer.
Journal Articles

Abstract #LB-197: Disruption of ligand induced HER2:HER3 inhibits tumor growth death and increases Paclitaxel-sensitivity in Breast Cancer Cells .

Jing Li, Ingrid Espinoza, Hong Liu, Ruth Lupu
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): LB-197.
Published: 01 May 2009
View article titled, Abstract #LB-197: Disruption of ligand induced HER2:HER3 inhibits tumor growth death and increases Paclitaxel-sensitivity in Breast Cancer Cells .
Journal Articles

Heregulin promotes Iressa-Resistance through stimulation HER-receptor Heterodimerization

Ruth Lupu, Jing Li, Anatilde Guerrico, Ingrid Espinoza, Hong Liu
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): LB-160.
Published: 01 May 2008
View article titled, Heregulin promotes Iressa-Resistance through stimulation HER-receptor Heterodimerization
Journal Articles

A novel thiosemicarbazone derivative TSC020502 with potent antitumor activity inhibits Topoisomerase IIα catalytic activity

Qin Chen, He Huang, Ling Meng, Cai Zhu, Ming Li, Hua Jiang, Li Lin, Hong Liu, Jian Ding
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 772.
Published: 01 May 2008
View article titled, A novel thiosemicarbazone derivative TSC020502 with potent antitumor activity inhibits Topoisomerase IIα catalytic activity
Journal Articles

Inhibition of fatty acid synthase promotes apoptosis in breast cancer cells via redox and energy stress

Binghui Li, Hong Liu, Ingrid Espinoza, Ruth Lupu
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 4364.
Published: 01 May 2008
View article titled, Inhibition of fatty acid synthase promotes apoptosis in breast cancer cells <em>via</em> redox and energy stress
Journal Articles

Induction of apoptosis and growth inhibition by cooperative effects of inhibitors for proteasome and fatty acid synthase in endocrine resistant breast cancer

Hong Liu, Binghui Li, Ruth Lupu
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 1339.
Published: 01 May 2008
View article titled, Induction of apoptosis and growth inhibition by cooperative effects of inhibitors for proteasome and fatty acid synthase in endocrine resistant breast cancer